1 Axial Therapeutics to Present at the Inaugural Virtual H.C. Wainwright BioConnect ConferenceJanuary 6, 2021 READ MORE
0 Axial Therapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company ConferenceDec. 8, 2020 READ MORE
17 Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other SymptomsDec. 3, 2020 READ MORE
0 Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceNovember 25, 2020 READ MORE
0 Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci CapitalNovember 16, 2020 READ MORE
0 Federico Bolognani, M.D., PH.D.Dr. Bolognani joins Axial Therapeutics with over 20 years of experience in translational neuroscience research in academia, pharmaceutical and the biotechnology industries. Most recently, [...] READ MORE
0 Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
